Evidence map›Paper›PMID 27141178›Full record

ReviewUrology annals

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.

Ashraf Abusamra, Esam Murshid, Hussain Kushi, Sultan Alkhateeb, Mubarak Al-Mansour, Ahmad Saadeddin, Danny Rabah, Shouki Bazarbashi, Mohammed Alotaibi, Abdullah Alghamdi and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Urology annals. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Prostate cancer among Saudis: a registry review.Annals of medicine and surgery (2012) · 2024
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Ashraf AbusamraDepartment of Surgery, Urology Section, King Khalid Hospital, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Esam MurshidDepartment of Oncology, Oncology Center, Prince Sultan Medical Military City, Riyadh, Saudi Arabia.
Hussain KushiDepartment of Radiation Oncology, Princess Norah Oncology Center, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Sultan AlkhateebDepartment of Surgery, Division of Urology, King Abdulaziz Medical City and King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Mubarak Al-MansourDepartment of Oncology, King Abdulaziz Medical City and King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Ahmad SaadeddinDepartment of Oncology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Danny RabahDepartment of Surgery, College of Medicine and Uro-Oncology Research Chair, King Saud University, Riyadh, Saudi Arabia.
Shouki BazarbashiDepartment of Oncology, Section of Medical Oncology, Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Mohammed AlotaibiDepartment of Urology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Abdullah AlghamdiDepartment of Urology, Prince Sultan Medical Military Center, Riyadh, Saudi Arabia.
Khalid AlghamdiDepartment of Surgery, Division of Urology, Security Forces Hospital, Riyadh, Saudi Arabia.
Abdullah AlsharmDepartment of Medical Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.
Imran AhmadDepartment of Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
King Abdulaziz Medical City · SANational Guard Health Affairs · SASecurity Forces Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is an update to the previously published Saudi guidelines for the evaluation, medical, and surgical management of patients diagnosed with prostate cancer. It is categorized according to the stage of the disease using the tumor node metastasis staging system 7(th) edition. The guidelines are presented with supporting evidence level, they are based on comprehensive literature review, several internationally recognized guidelines, and the collective expertise of the guidelines committee members (authors) who were selected by the Saudi oncology society and Saudi urological association. Considerations to the local availability of drugs, technology, and expertise have been regarded. These guidelines should serve as a roadmap for the urologists, oncologists, general physicians, support groups, and health care policy makers in the management of patients diagnosed with adenocarcinoma of the prostate to.

Indexed as

Guidelinesmanagementprostate cancerSaudi oncology societySaudi urological association

Identifiers

PMID27141178
PMCPMC4839225
OpenAlexW4246931631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.